2012, PhD in Molecular Virology, Purdue University, West Lafayette, Indiana, USA
2007, Bachelor & Master of Medicine, 7-Year Clinical Medicine Program, Nankai University, Tianjin, China
2013 - 2017 Postdoctoral Researcher, The Ohio State University, Columbus, OH, USA
2018 - present- Assistant Research Professor, Department of Hematology, City of Hope National Medical Center, Duarte, CA, USA
2017 - 2018- Research Scientist, Division of Hematology, The Ohio State University, Columbus, OH, USA
2007 - 2008- Research Assistant, National Institute of Biological Science, Beijing, China
2008, Purdue University PULSe Excellence Graduate Scholarship
2010, American Society of Virology travel award
2014, Pelotonia fellowship
American society for Virology
American association of immunologists
Dai HS*, Caligiuri MA*. Molecular basis for the interaction between HSV1 infection and human NK cells. Front Immunol. 2018 Feb 12;9:183. (* co-corresponding author)
Dai HS*, Griffin N, Bolyard C, Mao C, Zhang J, Cripe T, Suenaga T, Arase H, Nakano I, Chiocca E, Kaur B, Yu J, Caligiuri MA*. (2017).The Fc Domain of Immunoglobulin Is Sufficient to Bridge NK Cells with Virally Infected Cells. Immunity. Jul; 47 (1): 159-170 (* co-corresponding author)
Yoo JY, Jaime-Ramirez AC, Bolyard C, Dai HS, Nallanagulagari T, Wojton J, Hurwitz BS, Relation T, Lee TJ, Lotze MT, Yu JG, Zhang J, Croce CM, Yu J, Caligiuri MA, Old M, Kaur B. (2016).Bortezomib Treatment Sensitizes Oncolytic HSV-1-Treated Tumors to NK Cell Immunotherapy. Clin Cancer Res. Nov 1;22(21):5265-5276.
Dai HS*, Liu Z, Jiang W, Kuhn RJ*. (2013). Directed evolution of a virus exclusively utilizing human epidermal growth factor receptor as the entry receptor. J Virol. Oct;87(20):11231-43. (* co-corresponding author)